Braudon Yeo Invites You to Secure Your Spot at WFH 2026 World Congress
Braudon Yeo, Senior Manager, Sponsorship and Exhibit Sales at International Conference Services (ICS), reposted from Edwin Goh on LinkedIn:
”Looking to elevate your organization’s presence in the global bleeding disorders community?
The WFH 2026 World Congress in Kuala Lumpur is the ideal platform.
This premier international event brings together leaders, researchers, clinicians, and decision-makers shaping the future of hemophilia, VWD, and rare factor deficiencies.
With 147 days to go, now is the perfect time to secure your partnership or exhibition spot and position your organization for meaningful global impact.
- Showcase your expertise
- Connect with key influencers
- Strengthen your brand on a global stage
Interested in learning more?
Contact me at [email protected]
— I’d be thrilled to explore opportunities with you.”
Quoting Edwin Goh‘s post:
”Great news, everyone!
Exhibition opportunities for the WFH 2026 World Congress are now open!
If you’ve been thinking about showcasing your products, services, or innovations to a global community, this is the perfect chance.
And best part — it’s happening right here in Kuala Lumpur!
Come be part of an exciting, meaningful event.
Let’s make WFH 2026 an amazing experience together!”

Stay updated with Hemostasis Today.
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH